Bellevue Group Ag Sanofi Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Sanofi stock. As of the latest transaction made, Bellevue Group Ag holds 15,109 shares of SNY stock, worth $724,778. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,109

Holding current value

$724,778

% of portfolio

0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $733,390 - $884,329	15,109 New	15,109 $871,000
Q2 2022 Aug 11, 2022	SELL	$48.99 - $57.46 $63,687 - $74,698	-1,300 Reduced 2.98%	42,300 $2.12 Million
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $2.11 Million - $2.34 Million	43,600 New	43,600 $2.24 Million
Q4 2021 Feb 10, 2022	SELL	$47.07 - $52.35 $3.15 Million - $3.51 Million	-67,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $47,890 - $53,120	-1,000 Reduced 1.47%	67,000 $3.23 Million
Q2 2021 Aug 12, 2021	BUY	$49.36 - $54.25 $3.36 Million - $3.69 Million	68,000 New	68,000 $3.58 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $2.58 Million - $2.94 Million	-57,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $2.45 Million - $2.99 Million	57,000 New	57,000 $2.91 Million

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

Dodge & Cox San Francisco, CA

76.3M
Shares

$3.66 Billion
2.67% of portfolio
Morgan Stanley New York, NY

17.8M
Shares

$853 Million
0.08% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$641 Million
0.32% of portfolio
Invesco Ltd. Atlanta, GA

11.7M
Shares

$559 Million
0.13% of portfolio
Bank Of America Corp Charlotte, NC

11.6M
Shares

$555 Million
0.06% of portfolio

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account